Abstract:Objective:To investigate the molecular mechanism by which triamcinolone acetonide(TA ) may reduce edema in a SD rat model of retinal vein occlusion(RVO).Methods:After baseline ophthalmoscopic examination and fundus photography, a RVO was created photothrombotically in both eyes of 32 rats,using green photocoagulation and intravenous Rose Bengal. Following this,32 eyes were injected intravitreally with 320μg/8μl TA.After several days,all eyes were re-examined.Fluorescein angiography,in addition to ophthalmoscopy and fundus photography,was performed.Following sacrifice of the animals, the eyes were enucleated and processed,vascular endothelial growth factor(VEGF) was detected by ELISA and fluorescent immunohistochemistry,and compared and analyzed it by light microscope and image analysis software.Results:The changes of eye fundus amelioration were observed obviously in experimental group.Retinal VEGF levels were significantly lower in the TA-treated eyes as compared with the untreated eyes(P0.01).Conclusions:Intravitreal TA can down-regulate VEGF. This event may contribute to a reduction in the blood retinal barrier breakdown that occurs in RVO.

Effect of Triamcinolone Acetonide on Vascular Endothelial Growth Factor Levels in Experimental Retinal Vein Occlusion